Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

Posted On May 23, 2023 / By / Posted in Blog

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in

read more
Posted On April 25, 2023 / By / Posted in Blog

Dr. Abbey Featured in Retina Times

Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led

read more
Posted On February 21, 2023 / By / Posted in Blog

FDA Approves First Treatment for Geographic Atrophy

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved intravitreal pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Texas Retina

read more
Posted On February 6, 2023 / By / Posted in Blog

Dr. Abbey Featured in New Retina Radio Podcast

Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in a recently released New Retina Radio podcast for retina surgeons titled “Tips for Mastering Secondary IOLs.” Dr. Abbey discussed approaches to implanting

read more
Posted On January 5, 2023 / By / Posted in Blog

Retina Today Publishes Dr. Abbey’s Research on a Potential Toxic Side Effect of Some “Dropless” Cataract Surgery

“Dropless” cataract surgery has become more popular over the past decade and involves an injection of antibiotics and/or steroids into the eye at the time of surgery to eliminate the need for

read more
Posted On October 3, 2022 / By / Posted in Blog

Dr. Abbey Presented at the American Academy of Ophthalmology 2022 Meeting

Over the weekend, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a course titled “Secondary Intraocular Lens (IOL) Techniques for Retina Specialists” at the American Academy of Ophthalmology (AAO) 2022 meeting in Chicago,

read more
Posted On September 21, 2022 / By / Posted in Blog

Dr. Abbey Presented National Webinar on Treatment of Patients with Diabetic Macular Edema and 20/50 or Worse Vision

On Monday, September 19, 2022, Texas Retina Associates’ Ashkan M. Abbey, MD, delivered a webinar titled, “Does Treatment Selection Matter in Patients with Diabetic Macular Edema and 20/50 or Worse Vision?” Dr. Abbey discussed

read more
Posted On August 8, 2022 / By / Posted in Blog

Texas Retina Associates First in the Country to Dose a Patient in the DAVIO 2 Clinical Trial

Texas Retina Associates is honored to have randomized the first patient in EyePoint Pharmaceuticals’ Phase 2 “Durasert and Vorolanib in Ophthalmology 2” (DAVIO 2) clinical trial of EYP-1901 for patients with wet macular

read more
Posted On July 14, 2022 / By / Posted in Blog

Dr. Abbey Presents at the American Society of Retina Specialists 2022 Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD,  is presenting this week at the 40th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) in New York City. ASRS is the

read more
Posted On June 14, 2022 / By / Posted in Blog

Dr. Abbey’s Research Featured in New Retina Podcast

The medical journal Retina recently released a podcast featuring research by Texas Retina Associates’ Ashkan M. Abbey, MD, on clinical outcomes and surgical technique in transconjunctival sutureless intrascleral fixation of intraocular lenses

read more